Hematopoietic stem cell differ from progenitor stem cell in that they can –
## **Core Concept**
Hematopoietic stem cells (HSCs) and progenitor stem cells are crucial components in the process of hematopoiesis, which is the formation of blood cellular components. The primary distinction between these two types of cells lies in their capacity for self-renewal and differentiation. **Hematopoietic stem cells** possess the unique ability to self-renew and differentiate into all blood cell types, maintaining the hematopoietic system's integrity over a lifetime.
## **Why the Correct Answer is Right**
The correct answer, **D. self-renew**, highlights the key feature that distinguishes hematopoietic stem cells from progenitor stem cells. Hematopoietic stem cells have the capacity for **self-renewal**, which means they can divide to produce more hematopoietic stem cells, in addition to progenitor cells that will differentiate into specific blood cell lineages. This self-renewal capability is essential for maintaining a lifelong supply of blood cells and for the repopulation of the bone marrow after injury or transplantation.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While both hematopoietic stem cells and progenitor cells can differentiate into multiple cell types, the extent and flexibility of this differentiation potential are greater in hematopoietic stem cells. However, the ability to differentiate is not the key distinguishing feature.
- **Option B:** Progenitor cells can also proliferate, but the critical distinction lies in their limited ability to self-renew compared to hematopoietic stem cells.
- **Option C:** Although progenitor cells can undergo differentiation into more mature blood cells, this is not the distinguishing feature between hematopoietic stem cells and progenitor cells, as both can differentiate but to different extents.
## **Clinical Pearl / High-Yield Fact**
A crucial clinical pearl is that **hematopoietic stem cell transplantation** can cure various hematological disorders, including leukemias and lymphomas, by replacing a patient's damaged or malignant hematopoietic system with healthy functioning cells. The success of this procedure hinges on the ability of hematopoietic stem cells to self-renew and repopulate the bone marrow.
## **Correct Answer:** D. self-renew